Literature DB >> 16278749

Insulin and insulin resistance.

Gisela Wilcox1.   

Abstract

As obesity and diabetes reach epidemic proportions in the developed world, the role of insulin resistance and its consequences are gaining prominence. Understanding the role of insulin in wide-ranging physiological processes and the influences on its synthesis and secretion, alongside its actions from the molecular to the whole body level, has significant implications for much chronic disease seen in Westernised populations today. This review provides an overview of insulin, its history, structure, synthesis, secretion, actions and interactions followed by a discussion of insulin resistance and its associated clinical manifestations. Specific areas of focus include the actions of insulin and manifestations of insulin resistance in specific organs and tissues, physiological, environmental and pharmacological influences on insulin action and insulin resistance as well as clinical syndromes associated with insulin resistance. Clinical and functional measures of insulin resistance are also covered. Despite our incomplete understanding of the complex biological mechanisms of insulin action and insulin resistance, we need to consider the dramatic social changes of the past century with respect to physical activity, diet, work, socialisation and sleep patterns. Rapid globalization, urbanisation and industrialization have spawned epidemics of obesity, diabetes and their attendant co-morbidities, as physical inactivity and dietary imbalance unmask latent predisposing genetic traits.

Entities:  

Year:  2005        PMID: 16278749      PMCID: PMC1204764     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN: 0159-8090


  120 in total

1.  Insulin receptors in the pituitary gland: morphological evidence for influence on opioid peptide-synthesizing cells.

Authors:  J W Unger; W Lange
Journal:  Cell Tissue Res       Date:  1997-06       Impact factor: 5.249

2.  The effect of rate and dose of glucose infusion on the acute insulin response in man.

Authors:  M Chen; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1976-06       Impact factor: 5.958

Review 3.  Growth hormone deficiency and cardiovascular risk.

Authors:  F L Hew; D O'Neal; N Kamarudin; F P Alford; J D Best
Journal:  Baillieres Clin Endocrinol Metab       Date:  1998-07

Review 4.  Molecular mechanisms of insulin resistance that impact cardiovascular biology.

Authors:  Cecilia C Low Wang; Marc L Goalstone; Boris Draznin
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

Review 5.  Essential fatty acids in health and chronic disease.

Authors:  A P Simopoulos
Journal:  Am J Clin Nutr       Date:  1999-09       Impact factor: 7.045

Review 6.  The influence of different fats and fatty acids on obesity, insulin resistance and inflammation.

Authors:  George A Bray; Jennifer C Lovejoy; Steven R Smith; James P DeLany; Michael Lefevre; Daniel Hwang; Donna H Ryan; David A York
Journal:  J Nutr       Date:  2002-09       Impact factor: 4.798

7.  Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables.

Authors:  Francesco Tassone; Fabio Lanfranco; Laura Gianotti; Sonia Pivetti; Fabrizia Navone; Ruth Rossetto; Silvia Grottoli; Valerio Gai; Ezio Ghigo; Mauro Maccario
Journal:  Clin Endocrinol (Oxf)       Date:  2003-09       Impact factor: 3.478

8.  Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function.

Authors:  F Lanfranco; L Gianotti; S Pivetti; F Navone; R Rossetto; F Tassone; V Gai; E Ghigo; M Maccario
Journal:  Clin Endocrinol (Oxf)       Date:  2004-01       Impact factor: 3.478

Review 9.  Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system.

Authors:  S J Hunter; W T Garvey
Journal:  Am J Med       Date:  1998-10       Impact factor: 4.965

Review 10.  Metabolic abnormalities: triglyceride and low-density lipoprotein.

Authors:  Ronald M Krauss; Patty W Siri
Journal:  Endocrinol Metab Clin North Am       Date:  2004-06       Impact factor: 4.741

View more
  300 in total

1.  Revealing a Dual Role of Ganglioside Lipids in the Aggregation of Membrane-Associated Islet Amyloid Polypeptide.

Authors:  Mikkel Christensen; Birgit Schiøtt
Journal:  J Membr Biol       Date:  2019-06-20       Impact factor: 1.843

2.  Chemerin receptor blockade improves vascular function in diabetic obese mice via redox-sensitive and Akt-dependent pathways.

Authors:  Karla Bianca Neves; Aurelie Nguyen Dinh Cat; Rheure Alves-Lopes; Katie Yates Harvey; Rafael Menezes da Costa; Nubia Souza Lobato; Augusto Cesar Montezano; Ana Maria de Oliveira; Rhian M Touyz; Rita C Tostes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-09-14       Impact factor: 4.733

3.  Sleep and Glucose Intolerance/Diabetes Mellitus.

Authors:  Mary Ip; Babak Mokhlesi
Journal:  Sleep Med Clin       Date:  2007

Review 4.  Hepatitis C virus infection and insulin resistance.

Authors:  Sandip K Bose; Ranjit Ray
Journal:  World J Diabetes       Date:  2014-02-15

5.  Normal pregnancy- a state of insulin resistance.

Authors:  Amit D Sonagra; Shivaleela M Biradar; Dattatreya K; Jayaprakash Murthy D S
Journal:  J Clin Diagn Res       Date:  2014-11-20

Review 6.  Insulin resistance in obesity: an overview of fundamental alterations.

Authors:  Rocco Barazzoni; Gianluca Gortan Cappellari; Maurizio Ragni; Enzo Nisoli
Journal:  Eat Weight Disord       Date:  2018-02-03       Impact factor: 4.652

7.  Long-term glycemic control and prevention of diabetes complications in vivo using oleic acid-grafted-chitosan‑zinc-insulin complexes incorporated in thermosensitive copolymer.

Authors:  Divya Sharma; Jagdish Singh
Journal:  J Control Release       Date:  2020-04-10       Impact factor: 9.776

8.  Insulin secretion decline in Walker-256 tumor-bearing rats is early, follows the course of cachexia, and is not improved by lixisenatide.

Authors:  Débora Luiza Quintilhano; Daniele Romani Miksza; Winny Beatriz de Souza Galia; Mahira Oliveira Ramalho Costa Ramalho; Camila Ferraz Lucena; Maíra Mello Rezende Valle; Maria Fernanda Rodrigues Graciano; Helenir Medri de Souza; Gisele Lopes Bertolini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-31       Impact factor: 3.000

9.  Short acting insulin analogues in intensive care unit patients.

Authors:  Federico Bilotta; Carolina Guerra; Rafael Badenes; Simona Lolli; Giovanni Rosa
Journal:  World J Diabetes       Date:  2014-06-15

Review 10.  Diabetic keratopathy: Insights and challenges.

Authors:  S Priyadarsini; A Whelchel; S Nicholas; R Sharif; K Riaz; D Karamichos
Journal:  Surv Ophthalmol       Date:  2020-02-22       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.